A. Abdul-wahed, S. Guilmeau, and C. Postic, Sweet sixteenth for ChREBP: established roles and future goals, Cell Metab, vol.26, pp.324-341, 2017.

M. K. Badman, P. Pissios, A. R. Kennedy, G. Koukos, J. S. Flier et al., Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states, Cell Metab, vol.5, pp.426-437, 2007.

F. Benhamed, P. Denechaud, M. Lemoine, C. Robichon, M. Moldes et al., The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans, J. Clin. Invest, vol.122, pp.2176-2194, 2012.

Y. Benjamini and Y. Hochberg, Controlling the false discovery rate: A practical and powerful approach to multiple testing, Journal of the Royal Statistical Society. Series B (Methodological), vol.57, pp.289-300, 1995.

E. D. Berglund, C. Y. Li, H. A. Bina, S. E. Lynes, M. D. Michael et al., Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity, Endocrinology, vol.150, pp.4084-4093, 2009.

M. Boergesen, L. Poulsen, S. F. Schmidt, F. Frigerio, P. Maechler et al., ChREBP mediates glucose repression of peroxisome proliferator-activated receptor alpha expression in pancreatic beta-cells, 2011.

, J. Biol. Chem, vol.286, pp.13214-13225

J. D. Buenrostro, P. G. Giresi, L. C. Zaba, H. Y. Chang, and W. J. Greenleaf, Transposition of native chromatin for multimodal regulatory analysis and personal epigenomics, Nat. Methods, vol.10, pp.1213-1218, 2013.

K. T. Chambers, Z. Chen, L. Lai, T. C. Leone, H. C. Towle et al., PGC-1b and ChREBP partner to cooperatively regulate hepatic lipogenesis in a glucose concentration-dependent manner, Mol. Metab, vol.2, pp.194-204, 2013.

C. Christodoulides, P. Dyson, D. Sprecher, K. Tsintzas, and F. Karpe, , 2009.

, Circulating fibroblast growth factor 21 is induced by peroxisome proliferatoractivated receptor agonists but not ketosis in man, J. Clin. Endocrinol. Metab, vol.94, pp.3594-3601

T. Coskun, H. A. Bina, M. A. Schneider, J. D. Dunbar, C. C. Hu et al., Fibroblast growth factor 21 corrects obesity in mice, Endocrinology, vol.149, pp.6018-6027, 2008.

R. Dentin, J. P. Pé-gorier, F. Benhamed, F. Foufelle, P. Ferré et al., Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression, J. Biol. Chem, vol.279, pp.20314-20326, 2004.

S. Falcon and R. Gentleman, Using GOstats to test gene lists for GO term association, Bioinformatics, vol.23, pp.257-258, 2007.

F. M. Fisher, J. L. Estall, A. C. Adams, P. J. Antonellis, H. A. Bina et al., Integrated regulation of hepatic metabolism by fibroblast growth factor 21 (FGF21) in vivo, Endocrinology, vol.152, pp.2996-3004, 2011.

C. Gä-lman, T. Lundå-sen, A. Kharitonenkov, H. A. Bina, M. Eriksson et al., The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man, Cell Metab, vol.8, pp.169-174, 2008.

R. C. Gentleman, V. J. Carey, D. M. Bates, B. Bolstad, M. Dettling et al., Bioconductor: open software development for computational biology and bioinformatics, vol.5, p.80, 2004.

N. G. Girer, I. A. Murray, C. J. Omiecinski, and G. H. Perdew, Hepatic aryl hydrocarbon receptor attenuates fibroblast growth factor 21 expression, J. Biol. Chem, vol.291, pp.15378-15387, 2016.

I. Goldstein and G. L. Hager, Transcriptional and chromatin regulation during fasting: the genomic era, Trends Endocrinol. Metab, vol.26, pp.699-710, 2015.

M. A. Herman, O. D. Peroni, J. Villoria, M. R. Schö-n, N. A. Abumrad et al., A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism, Nature, vol.484, pp.333-338, 2012.

K. Iizuka, J. Takeda, and Y. Horikawa, Glucose induces FGF21 mRNA expression through ChREBP activation in rat hepatocytes, FEBS Lett, vol.583, pp.2882-2886, 2009.

K. Iizuka, W. Wu, Y. Horikawa, M. Saito, and J. Takeda, Feedback looping between ChREBP and PPARa in the regulation of lipid metabolism in brown adipose tissues, Endocr. J, vol.60, pp.1145-1153, 2013.

Y. Imai, E. Ohta, S. Takeda, S. Sunamura, M. Ishibashi et al., Histone deacetylase inhibitor panobinostat induces calcineurin degradation in multiple myeloma, JCI Insight, vol.1, p.85061, 2016.

T. Inagaki, P. Dutchak, G. Zhao, X. Ding, L. Gautron et al., Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21, Cell Metab, vol.5, pp.415-425, 2007.

A. Iroz, J. P. Couty, and C. Postic, Hepatokines: unlocking the multiorgan network in metabolic diseases, Diabetologia, vol.58, pp.1699-1703, 2015.

D. Jaeger, G. Schoiswohl, P. Hofer, R. Schreiber, M. Schweiger et al., Fasting-induced G0/G1 switch gene 2 and FGF21 expression in the liver are under regulation of adipose tissue derived fatty acids, J. Hepatol, vol.63, pp.437-445, 2015.

T. Jois, C. Chen, V. Howard, R. Harvey, K. Youngs et al., Deletion of hepatic carbohydrate response element binding protein (ChREBP) impairs glucose homeostasis and hepatic insulin sensitivity in mice, Mol. Metab, 2017.

T. Kawaguchi, M. Takenoshita, T. Kabashima, and K. Uyeda, Glucose and cAMP regulate the L-type pyruvate kinase gene by phosphorylation/dephosphorylation of the carbohydrate response element binding protein, Proc. Natl. Acad. Sci. USA, vol.98, pp.13710-13715, 2001.

S. Kersten, J. Seydoux, J. M. Peters, F. J. Gonzalez, B. Desvergne et al., Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting, J. Clin. Invest, vol.103, pp.1489-1498, 1999.

A. Kharitonenkov, A. , and A. C. , Inventing new medicines: The FGF21 story, Mol. Metab, vol.3, pp.221-229, 2013.

A. Kharitonenkov, V. J. Wroblewski, A. Koester, Y. F. Chen, C. K. Clutinger et al., The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21, Endocrinology, vol.148, pp.774-781, 2007.

D. L. Kroetz, P. Yook, P. Costet, P. Bianchi, and T. Pineau, Peroxisome proliferator-activated receptor alpha controls the hepatic CYP4A induction adaptive response to starvation and diabetes, J. Biol. Chem, vol.273, pp.31581-31589, 1998.

T. C. Leone, C. J. Weinheimer, and D. P. Kelly, A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders, Proc. Natl. Acad. Sci. USA, vol.96, pp.7473-7478, 1999.

M. V. Li, B. Chang, M. Imamura, N. Poungvarin, C. et al., , 2006.

, Glucose-dependent transcriptional regulation by an evolutionarily conserved glucose-sensing module, Diabetes, vol.55, pp.1179-1189

T. Lundå-sen, M. C. Hunt, L. Nilsson, S. Sanyal, B. Angelin et al., PPARalpha is a key regulator of hepatic FGF21, Biochem. Biophys. Res. Commun, vol.360, pp.437-440, 2007.

K. R. Markan, M. C. Naber, M. K. Ameka, M. D. Anderegg, D. J. Mangelsdorf et al., Circulating FGF21 is liver derived and enhances glucose uptake during refeeding and overfeeding, Diabetes, vol.63, pp.4057-4063, 2014.

S. Marmier, R. Dentin, M. Daujat-chavanieu, H. Guillou, J. Bertrand-michel et al., Novel role for carbohydrate responsive element binding protein in the control of ethanol metabolism and susceptibility to binge drinking, Hepatology, vol.62, pp.1086-1100, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01838005

A. Montagner, A. Polizzi, E. Fouché, S. Ducheix, Y. Lippi et al., Liver PPARa is crucial for whole-body fatty acid homeostasis and is protective against NAFLD, Gut, vol.65, pp.1202-1214, 2016.

K. L. Ong, K. Rye, R. O'connell, A. J. Jenkins, C. Brown et al., , 2012.

, Long-term fenofibrate therapy increases fibroblast growth factor 21 and retinol-binding protein 4 in subjects with type 2 diabetes, J. Clin. Endocrinol. Metab, vol.97, pp.4701-4708

L. Pichard, E. Raulet, G. Fabre, J. B. Ferrini, J. Ourlin et al., Human hepatocyte culture, Methods Mol. Biol, vol.320, pp.283-293, 2006.

M. J. Potthoff, T. Inagaki, S. Satapati, X. Ding, T. He et al., FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response, Proc. Natl. Acad. Sci. USA, vol.106, pp.10853-10858, 2009.

G. Rando, C. K. Tan, N. Khaled, A. Montagner, N. Leuenberger et al., Glucocorticoid receptor-PPARa axis in fetal mouse liver prepares neonates for milk lipid catabolism, p.11853, 2016.

J. Sá-nchez, A. Palou, and C. Picó, Response to carbohydrate and fat refeeding in the expression of genes involved in nutrient partitioning and metabolism: striking effects on fibroblast growth factor-21 induction, Endocrinology, vol.150, pp.5341-5350, 2009.

J. M. Simon, P. G. Giresi, I. J. Davis, and J. D. Lieb, Using formaldehyde-assisted isolation of regulatory elements (FAIRE) to isolate active regulatory DNA, Nat. Protoc, vol.7, pp.256-267, 2012.

S. Talukdar, B. M. Owen, P. Song, G. Hernandez, Y. Zhang et al., FGF21 Regulates Sweet and Alcohol Preference, vol.23, pp.344-349, 2016.

T. Uebanso, Y. Taketani, H. Yamamoto, K. Amo, H. Ominami et al., Paradoxical regulation of human FGF21 by both fasting and feeding signals: is FGF21 a nutritional adaptation factor?, PLoS ONE, vol.6, 2011.

R. B. Vega, J. M. Huss, and D. P. Kelly, The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes, Mol. Cell. Biol, vol.20, pp.1868-1876, 2000.

S. Von-holstein-rathlou, L. D. Bondurant, L. Peltekian, M. C. Naber, T. C. Yin et al., FGF21 mediates endocrine control of simple sugar intake and sweet taste preference by the liver, Cell Metab, vol.23, pp.335-343, 2016.

J. M. Wettenhall and G. K. Smyth, limmaGUI: a graphical user interface for linear modeling of microarray data, Bioinformatics, vol.20, pp.3705-3706, 2004.

J. C. Yoon, P. Puigserver, G. Chen, J. Donovan, Z. Wu et al., Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1, Nature, vol.413, pp.131-138, 2001.

K. S. Zaret and J. S. Carroll, Pioneer transcription factors: establishing competence for gene expression, Genes Dev, vol.25, pp.2227-2241, 2011.